Subsequently, we screened and analysed 20 drugs that were most closely associated with GABARAPL1, utilising a heat map to elucidate their underlying mechanisms of action (MOA) in MI patients (Figure S5A). This evidence concerns the gene GABARAPL1 and myocardial infarction.